{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:01:09Z","timestamp":1791295269353,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2001,6,1]]},"DOI":"10.1038\/sj.leu.2402125","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T21:05:13Z","timestamp":1032469513000},"page":"981-986","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":120,"title":["Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy"],"prefix":"10.1038","volume":"15","author":[{"given":"R","family":"Fonseca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MM","family":"Oken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RJ","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SA","family":"Van Wier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KJ","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NE","family":"Kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Van Ness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PR","family":"Greipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GW","family":"Dewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2001,7,5]]},"reference":[{"key":"BF2402125_CR1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1182\/blood.V66.2.380.380","volume":"66","author":"GW Dewald","year":"1985","unstructured":"Dewald GW, Kyle RA, Hicks GA, Greipp PR . The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis Blood 1985 66: 380\u2013390","journal-title":"Blood"},{"key":"BF2402125_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0165-4608(94)00284-I","volume":"82","author":"JR Sawyer","year":"1995","unstructured":"Sawyer JR, Waldron JA, Jagannath S, Barlogie B . Cytogenetic findings in 200 patients with multiple myeloma Cancer Genet Cytogenet 1995 82: 41\u201349","journal-title":"Cancer Genet Cytogenet"},{"key":"BF2402125_CR3","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1365-2141.1995.tb05593.x","volume":"90","author":"NV Smadja","year":"1995","unstructured":"Smadja NV, Louvet C, Isnard F et al. Cytogenetic study in multiple myeloma at diagnosis: comparison of two techniques Br J Haematol 1995 90: 619\u2013624","journal-title":"Br J Haematol"},{"key":"BF2402125_CR4","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/(SICI)1098-2264(199706)19:2<124::AID-GCC8>3.0.CO;2-0","volume":"19","author":"H Avet-Loiseau","year":"1997","unstructured":"Avet-Loiseau H, Andree-Ashley LE, Moore D 2nd et al. Molecular cytogenetic abnormalities in multiple myeloma and plasma cell leukemia measured using comparative genomic hybridization Genes Chromos Cancer 1997 19: 124\u2013133","journal-title":"Genes Chromos Cancer"},{"key":"BF2402125_CR5","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood.V91.8.3007.3007_3007_3010","volume":"91","author":"JC Cigudosa","year":"1998","unstructured":"Cigudosa JC, Rao PH, Calasanz MJ et al. Characterization of nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridization Blood 1998 91: 3007\u20133010","journal-title":"Blood"},{"key":"BF2402125_CR6","first-page":"1743","volume":"92","author":"PH Rao","year":"1998","unstructured":"Rao PH, Cigudosa JC, Ning Y et al. Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma Blood 1998 92: 1743\u20131748","journal-title":"Blood"},{"key":"BF2402125_CR7","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1182\/blood.V92.11.4269","volume":"92","author":"JR Sawyer","year":"1998","unstructured":"Sawyer JR, Lukacs JL, Munshi N et al. Identification of new nonrandom translocations in multiple myeloma with multicolor spectral karyotyping Blood 1998 92: 4269\u20134278","journal-title":"Blood"},{"key":"BF2402125_CR8","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1182\/blood.V86.11.4250.bloodjournal86114250","volume":"86","author":"G Tricot","year":"1995","unstructured":"Tricot G, Barlogie B, Jagannath S et al. Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities Blood 1995 86: 4250\u20134256","journal-title":"Blood"},{"key":"BF2402125_CR9","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1200\/JCO.1997.15.7.2659","volume":"15","author":"G Tricot","year":"1997","unstructured":"Tricot G, Sawyer JR, Jagannath S et al. Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants J Clin Oncol 1997 15: 2659\u20132666","journal-title":"J Clin Oncol"},{"key":"BF2402125_CR10","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1200\/JCO.2000.18.4.804","volume":"18","author":"R Konigsberg","year":"2000","unstructured":"Konigsberg R, Zojer N, Ackermann J et al. Predictive role of interphase cytogenetics for survival of patients with multiple myeloma J Clin Oncol 2000 18: 804\u2013812","journal-title":"J Clin Oncol"},{"key":"BF2402125_CR11","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1182\/blood.V95.6.1925","volume":"95","author":"N Zojer","year":"2000","unstructured":"Zojer N, Konigsberg R, Ackermann J et al. Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization Blood 2000 95: 1925\u20131930","journal-title":"Blood"},{"key":"BF2402125_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0165-4608(97)00408-1","volume":"103","author":"AL Juneau","year":"1998","unstructured":"Juneau AL, Kaehler M, Christensen ER et al. Detection of RB1 deletions by fluorescence in situ hybridization in malignant hematologic disorders Cancer Genet Cytogenet 1998 103: 117\u2013123","journal-title":"Cancer Genet Cytogenet"},{"key":"BF2402125_CR13","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1182\/blood.V94.8.2583.420a05_2583_2589","volume":"94","author":"H Avet-Loiseau","year":"1999","unstructured":"Avet-Loiseau H, Li JY, Morineau N et al. Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma. Intergroupe Francophone du Myelome Blood 1999 94: 2583\u20132589","journal-title":"Blood"},{"key":"BF2402125_CR14","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood.V96.4.1505","volume":"96","author":"J Shaughnessy","year":"2000","unstructured":"Shaughnessy J, Tian E, Sawyer J et al. High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH Blood 2000 96: 1505\u20131511","journal-title":"Blood"},{"key":"BF2402125_CR15","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/(SICI)1097-0142(19990915)86:6<957::AID-CNCR10>3.0.CO;2-8","volume":"86","author":"MM Oken","year":"1999","unstructured":"Oken MM, Leong T, Lenhard RE Jr et al. The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma: phase III Eastern Cooperative Oncology Group Clinical Trial EST 9486 Cancer 1999 86: 957\u2013968","journal-title":"Cancer"},{"key":"BF2402125_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0165-4608(97)00058-7","volume":"101","author":"GJ Ahmann","year":"1998","unstructured":"Ahmann GJ, Jalal SM, Juneau AL et al. A novel three-color, clone-specific fluorescence in situ hybridization procedure for monoclonal gammopathies Cancer Genet Cytogenet 1998 101: 7\u201311","journal-title":"Cancer Genet Cytogenet"},{"key":"BF2402125_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1006\/geno.1997.4747","volume":"42","author":"S Kalachikov","year":"1997","unstructured":"Kalachikov S, Migliazza A, Cayanis E et al. Cloning and gene mapping of the chromosome 13q14 region deleted in chronic lymphocytic leukemia Genomics 1997 42: 369\u2013377","journal-title":"Genomics"},{"key":"BF2402125_CR18","first-page":"4546","volume":"59","author":"H Avet-Loiseau","year":"1999","unstructured":"Avet-Loiseau H, Facon T, Daviet A et al. 14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myelome Cancer Res 1999 59: 4546\u20134550","journal-title":"Cancer Res"},{"key":"BF2402125_CR19","first-page":"113","volume":"9","author":"Jr Knudson AG","year":"1973","unstructured":"Knudson AG Jr, Strong LC, Anderson DE . Heredity and cancer in man Prog Med Genet 1973 9: 113\u2013158","journal-title":"Prog Med Genet"},{"key":"BF2402125_CR20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1006\/geno.1997.5008","volume":"46","author":"I Bouyge-Moreau","year":"1997","unstructured":"Bouyge-Moreau I, Rondeau G, Avet-Loiseau H et al. Construction of a 780-kb PAC, BAC, and cosmid contig encompassing the minimal critical deletion involved in B cell chronic lymphocytic leukemia at 13q14.3 Genomics 1997 46: 183\u2013190","journal-title":"Genomics"},{"key":"BF2402125_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/ng0193-67","volume":"3","author":"AG Brown","year":"1993","unstructured":"Brown AG, Ross FM, Dunne EM, Steel CM, Weir-Thompson EM . Evidence for a new tumour suppressor locus (DBM) in human B-cell neoplasia telomeric to the retinoblastoma gene Nat Genet 1993 3: 67\u201372","journal-title":"Nat Genet"},{"key":"BF2402125_CR22","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1038\/sj.onc.1201764","volume":"16","author":"S Stilgenbauer","year":"1998","unstructured":"Stilgenbauer S, Nickolenko J, Wilhelm J et al. Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma Oncogene 1998 16: 1891\u20131897","journal-title":"Oncogene"},{"key":"BF2402125_CR23","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1182\/blood.V91.4.1382","volume":"91","author":"MM Corcoran","year":"1998","unstructured":"Corcoran MM, Rasool O, Liu Y et al. Detailed molecular delineation of 13q14.3 loss in B-cell chronic lymphocytic leukemia Blood 1998 91: 1382\u20131390","journal-title":"Blood"},{"key":"BF2402125_CR24","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1182\/blood.V88.5.1568.1568","volume":"88","author":"JA Garcia-Marco","year":"1996","unstructured":"Garcia-Marco JA, Caldas C, Price CM, Wiedemann LM, Ashworth A, Catovsky D . Frequent somatic deletion of the 13q12.3 locus encompassing BRCA2 in chronic lymphocytic leukemia Blood 1996 88: 1568\u20131575","journal-title":"Blood"},{"key":"BF2402125_CR25","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1182\/blood.V88.8.3109.bloodjournal8883109","volume":"88","author":"F Bullrich","year":"1996","unstructured":"Bullrich F, Veronese ML, Kitada S et al. Minimal region of loss at 13q14 in B-cell chronic lymphocytic leukemia Blood 1996 88: 3109\u20133115","journal-title":"Blood"},{"key":"BF2402125_CR26","first-page":"S19","volume":"11","author":"H Dohner","year":"1997","unstructured":"Dohner H, Stilgenbauer S, Fischer K, Bentz M, Lichter P . Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes Leukemia 1997 11: S19\u2013S24","journal-title":"Leukemia"},{"key":"BF2402125_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0165-4608(96)00246-4","volume":"94","author":"J Dierlamm","year":"1997","unstructured":"Dierlamm J, Michaux L, Criel A, Wlodarska I, Van den Berghe H, Hossfeld DK . Genetic abnormalities in chronic lymphocytic leukemia and their clinical and prognostic implications Cancer Genet Cytogenet 1997 94: 27\u201335","journal-title":"Cancer Genet Cytogenet"},{"key":"BF2402125_CR28","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/sj.leu.2400920","volume":"12","author":"M Merup","year":"1998","unstructured":"Merup M, Jansson M, Corcoran M et al. A FISH cosmid \u2018cocktail\u2019 for detection of 13q deletions in chronic lymphocytic leukaemia \u2013 comparison with cytogenetics and Southern hybridization Leukemia 1998 12: 705\u2013709","journal-title":"Leukemia"},{"key":"BF2402125_CR29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/(SICI)1097-0215(20000401)86:1<76::AID-IJC12>3.0.CO;2-U","volume":"86","author":"M Dominici","year":"2000","unstructured":"Dominici M, Luppi M, Campioni D et al. PCR with degenerate primers for highly conserved DNA polymerase gene of the herpesvirus family shows neither human herpesvirus 8 nor a related variant in bone marrow stromal cells from multiple myeloma patients Int J Cancer 2000 86: 76\u201382","journal-title":"Int J Cancer"},{"key":"BF2402125_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0165-4608(99)00009-6","volume":"113","author":"SV Rajkumar","year":"1999","unstructured":"Rajkumar SV, Fonseca R, Dewald GW et al. Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myeloma Cancer Genet Cytogenet 1999 113: 73\u201377","journal-title":"Cancer Genet Cytogenet"},{"key":"BF2402125_CR31","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1182\/blood.V91.9.3366","volume":"91","author":"JA Perez-Simon","year":"1998","unstructured":"Perez-Simon JA, Garcia-Sanz R, Tabernero MD et al. Prognostic value of numerical chromosome aberrations in multiple myeloma: a FISH analysis of 15 different chromosomes Blood 1998 91: 3366\u20133371","journal-title":"Blood"},{"key":"BF2402125_CR32","first-page":"547a","volume":"96","author":"R Fonseca","year":"2000","unstructured":"Fonseca R, Harrington D, Oken MM et al. Prognostic significance of 13q\u2212 deletions and the t(11;14)(q13;q32) in myeloma (MM); an interphase FISH study of 351 patients entered into the Eastern Cooperative Oncology Group E9487 Clinical Trial Blood 2000 96: 547a","journal-title":"Blood"},{"key":"BF2402125_CR33","first-page":"4887","volume":"19","author":"P Duesberg","year":"1999","unstructured":"Duesberg P, Rasnick D, Li R, Winters L, Rausch C, Hehlmann R . How aneuploidy may cause cancer and genetic instability Anticancer Res 1999 19: 4887\u20134906","journal-title":"Anticancer Res"},{"key":"BF2402125_CR34","doi-asserted-by":"publisher","first-page":"13692","DOI":"10.1073\/pnas.95.23.13692","volume":"95","author":"P Duesberg","year":"1998","unstructured":"Duesberg P, Rausch C, Rasnick D, Hehlmann R . Genetic instability of cancer cells is proportional to their degree of aneuploidy Proc Natl Acad Sci USA 1998 95: 13692\u201313697","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2402125_CR35","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.V92.3.802","volume":"92","author":"J Drach","year":"1998","unstructured":"Drach J, Ackermann J, Fritz E et al. Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy Blood 1998 92: 802\u2013809","journal-title":"Blood"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2402125.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402125","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402125.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:57:19Z","timestamp":1648763839000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2402125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6,1]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,6,1]]}},"alternative-id":["BF2402125"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2402125","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6,1]]},"assertion":[{"value":"7 November 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2001","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2001","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}